124 related articles for article (PubMed ID: 17317177)
21. Synthesis and SAR of novel histamine H3 receptor antagonists.
Jesudason CD; Beavers LS; Cramer JW; Dill J; Finley DR; Lindsley CW; Stevens FC; Gadski RA; Oldham SW; Pickard RT; Siedem CS; Sindelar DK; Singh A; Watson BM; Hipskind PA
Bioorg Med Chem Lett; 2006 Jul; 16(13):3415-8. PubMed ID: 16677814
[TBL] [Abstract][Full Text] [Related]
22. Novel human histamine H(3) receptor antagonists.
Shah C; McAtee L; Breitenbucher JG; Rudolph D; Li X; Lovenberg TW; Mazur C; Wilson SJ; Carruthers NI
Bioorg Med Chem Lett; 2002 Nov; 12(22):3309-12. PubMed ID: 12392739
[TBL] [Abstract][Full Text] [Related]
23. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
24. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
25. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
[TBL] [Abstract][Full Text] [Related]
26. Ligand based design of novel histamine H₄ receptor antagonists; fragment optimization and analysis of binding kinetics.
Smits RA; Lim HD; van der Meer T; Kuhne S; Bessembinder K; Zuiderveld OP; Wijtmans M; de Esch IJ; Leurs R
Bioorg Med Chem Lett; 2012 Jan; 22(1):461-7. PubMed ID: 22153663
[TBL] [Abstract][Full Text] [Related]
27. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
[TBL] [Abstract][Full Text] [Related]
28. 4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
Pechulis AD; Beck JP; Curry MA; Wolf MA; Harms AE; Xi N; Opalka C; Sweet MP; Yang Z; Vellekoop AS; Klos AM; Crocker PJ; Hassler C; Laws M; Kitchen DB; Smith MA; Olson RE; Liu S; Molino BF
Bioorg Med Chem Lett; 2012 Dec; 22(23):7219-22. PubMed ID: 23084899
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.
Becknell NC; Dandu RR; Lyons JA; Aimone LD; Raddatz R; Hudkins RL
Bioorg Med Chem Lett; 2012 Jan; 22(1):186-9. PubMed ID: 22153342
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.
Wu YJ; He H; Gao Q; Wu D; Bertekap R; Westphal RS; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
Bioorg Med Chem Lett; 2014 Mar; 24(6):1611-4. PubMed ID: 24507922
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
Ly KS; Letavic MA; Keith JM; Miller JM; Stocking EM; Barbier AJ; Bonaventure P; Lord B; Jiang X; Boggs JD; Dvorak L; Miller KL; Nepomuceno D; Wilson SJ; Carruthers NI
Bioorg Med Chem Lett; 2008 Jan; 18(1):39-43. PubMed ID: 18060777
[TBL] [Abstract][Full Text] [Related]
32. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of histamine H
Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems.
Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M
Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166
[TBL] [Abstract][Full Text] [Related]
35. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
Dvorak CA; Apodaca R; Barbier AJ; Berridge CW; Wilson SJ; Boggs JD; Xiao W; Lovenberg TW; Carruthers NI
J Med Chem; 2005 Mar; 48(6):2229-38. PubMed ID: 15771465
[TBL] [Abstract][Full Text] [Related]
36. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
Wolin R; Connolly M; Afonso A; Hey JA; She H; Rivelli MA; Willams SM; West RE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2157-62. PubMed ID: 9873505
[TBL] [Abstract][Full Text] [Related]
37. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
[TBL] [Abstract][Full Text] [Related]
38. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
[TBL] [Abstract][Full Text] [Related]
39. 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; McDonald IM; Pether MJ; Steel KI
Bioorg Med Chem Lett; 1999 Nov; 9(21):3103-8. PubMed ID: 10560733
[TBL] [Abstract][Full Text] [Related]
40. Acidic elements in histamine H(3) receptor antagonists.
Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
